(HealthDay)—For patients with eosinophilic asthma, mepolizumab has a glucocorticoid-sparing effect and reduces exacerbations when administered intravenously or subcutaneously, according to two studies published online Sept. ...
Sep 9, 2014
0
0
Clinical trials of vaccines for the deadly Ebola virus should soon get underway and will likely be ready for widespread use by early next year, the World Health Organization said Saturday.
Aug 9, 2014
1
0
Swiss pharmaceutical firm Novartis AG launched a major overhaul of its business Tuesday, unveiling a series of multibillion-dollar deals with Britain's GlaxoSmithKline PLC and the U.S.'s Eli Lilly & Co. that heralds more ...
Apr 22, 2014
0
0
Some of the world's biggest drugmakers are playing a larger role in anti-doping efforts at this year's Winter Olympics: They're providing information on drugs that once would have been considered proprietary trade secrets.
Feb 7, 2014
0
0
A potential GlaxoSmithKline heart disease treatment acquired in a key company takeover fell short in a big, late-stage study.
Nov 12, 2013
0
0
(HealthDay)—Oral pazopanib is well tolerated and improves mean best-corrected visual acuity, central retinal lesion thickness, and central retinal thickness at day 29 in a small, per-protocol, non-rescued population of ...
Oct 11, 2013
0
0
(HealthDay)—Recent influenza does not predict acute myocardial infarction (AMI), but vaccination offers a significant protective benefit for the prevention of AMI, according to research published online Aug. 21 in Heart.
Aug 22, 2013
0
0
(HealthDay)—Tivicay (dolutegravir) has been approved by the U.S. Food and Drug Administration to treat infection with HIV-1, a strain of the virus that causes AIDS.
Aug 13, 2013
0
0
(HealthDay)—The U.S Food and Drug Administration has approved shipping of the first vaccine to protect against four strains of seasonal flu.
Aug 6, 2013
0
0
India has revoked a local patent granted to Britain's GlaxoSmithKline for a breast cancer drug in the latest blow to global companies seeking a bigger presence in the country's $13 billion medicine market.
Aug 2, 2013
0
0
